Olsen Jan Roger, Azeem Waqas, Hellem Margrete Reime, Marvyin Kristo, Hua Yaping, Qu Yi, Li Lisha, Lin Biaoyang, Ke Xi- Song, Øyan Anne Margrete, Kalland Karl- Henning
Department of Clinical Science, University of Bergen, Bergen, Norway.
, Laboratory Bld. 5. etg, Bergen Health, Bergen, NO-5021, Norway.
BMC Cancer. 2016 Jul 4;16:377. doi: 10.1186/s12885-016-2453-4.
Expression of the androgen receptor (AR) is associated with androgen-dependent proliferation arrest and terminal differentiation of normal prostate epithelial cells. Additionally, activation of the AR is required for survival of benign luminal epithelial cells and primary cancer cells, thus androgen deprivation therapy (ADT) leads to apoptosis in both benign and cancerous tissue. Escape from ADT is known as castration-resistant prostate cancer (CRPC). In the course of CRPC development the AR typically switches from being a cell-intrinsic inhibitor of normal prostate epithelial cell proliferation to becoming an oncogene that is critical for prostate cancer cell proliferation. A clearer understanding of the context dependent activation of the AR and its target genes is therefore desirable.
Immortalized human prostate basal epithelial EP156T cells and progeny cells that underwent epithelial to mesenchymal transition (EMT), primary prostate epithelial cells (PrECs) and prostate cancer cell lines LNCaP, VCaP and 22Rv1 were used to examine context dependent restriction and activation of the AR and classical target genes, such as KLK3. Genome-wide gene expression analyses and single cell protein analyses were applied to study the effect of different contexts.
A variety of growth conditions were tested and found unable to activate AR expression and transcription of classical androgen-dependent AR target genes, such as KLK3, in prostate epithelial cells with basal cell features or in mesenchymal type prostate cells. The restriction of androgen- and AR-dependent transcription of classical target genes in prostate basal epithelial cells was at the level of AR expression. Exogenous AR expression was sufficient for androgen-dependent transcription of AR target genes in prostate basal epithelial cells, but did not exert a positive feedback on endogenous AR expression. Treatment of basal prostate epithelial cells with inhibitors of epigenetic gene silencing was not efficient in inducing androgen-dependent transcription of AR target genes, suggesting the importance of missing cofactor(s).
Regulatory mechanisms of AR and androgen-dependent AR target gene transcription are insufficiently understood and may be critical for prostate cancer initiation, progression and escape from standard therapy. The present model is useful for the study of context dependent activation of the AR and its transcriptome.
雄激素受体(AR)的表达与正常前列腺上皮细胞的雄激素依赖性增殖停滞和终末分化相关。此外,良性管腔上皮细胞和原发性癌细胞的存活需要AR的激活,因此雄激素剥夺疗法(ADT)会导致良性和癌组织中的细胞凋亡。对ADT产生逃逸的情况被称为去势抵抗性前列腺癌(CRPC)。在CRPC发展过程中,AR通常从正常前列腺上皮细胞增殖的细胞内源性抑制剂转变为对前列腺癌细胞增殖至关重要的癌基因。因此,更清楚地了解AR及其靶基因的上下文依赖性激活是很有必要的。
使用永生化的人前列腺基底上皮EP156T细胞及其经历上皮-间质转化(EMT)的子代细胞、原代前列腺上皮细胞(PrECs)以及前列腺癌细胞系LNCaP、VCaP和22Rv1来检测AR及其经典靶基因(如KLK3)的上下文依赖性限制和激活。应用全基因组基因表达分析和单细胞蛋白质分析来研究不同背景的影响。
测试了多种生长条件,发现它们无法激活具有基底细胞特征的前列腺上皮细胞或间充质型前列腺细胞中AR的表达以及经典雄激素依赖性AR靶基因(如KLK3)的转录。前列腺基底上皮细胞中经典靶基因的雄激素和AR依赖性转录的限制在于AR表达水平。外源性AR表达足以在前列腺基底上皮细胞中实现AR靶基因的雄激素依赖性转录,但对内源性AR表达没有产生正反馈。用表观遗传基因沉默抑制剂处理基底前列腺上皮细胞在诱导AR靶基因的雄激素依赖性转录方面并不有效,这表明缺少辅助因子的重要性。
对AR和雄激素依赖性AR靶基因转录的调控机制了解不足,这可能对前列腺癌的起始、进展以及从标准治疗中逃逸至关重要。当前模型对于研究AR及其转录组的上下文依赖性激活很有用。